ANTM:NYE-Anthem, Inc (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 379.78

Change

-5.06 (-1.31)%

Market Cap

USD 93.41B

Volume

1.14M

Average Target Price

USD 386.78 (+1.84%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2020, it served 43 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-22 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

-2.27 (-0.57%)

USD377.00B 22.68 14.47
CVS CVS Health Corporation

-0.52 (-0.68%)

USD100.67B 14.04 10.15
CI Cigna Corporation

-0.46 (-0.18%)

USD87.89B 11.02 N/A
HUM Humana Inc

+0.21 (+0.05%)

USD57.15B 17.50 N/A
CNC Centene Corporation

-0.85 (-1.30%)

USD38.09B 20.99 9.24
MOH Molina Healthcare, Inc

-1.27 (-0.50%)

USD14.87B 22.48 9.50
GTS Triple-S Management Corporatio..

-0.56 (-2.14%)

USD0.62B 9.09 N/A

ETFs Containing ANTM

Symbol Name Weight Mer Price(Change) Market Cap
BIV Vanguard Intermediate-Ter.. 0.00 % 0.05 %

+0.04 (+0.04%)

USD38.57B
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.50 %

+7.00 (+1.06%)

N/A
IBCZ:XETRA iShares Edge MSCI World M.. 0.00 % 0.50 %

+0.04 (+0.56%)

USD0.54B
IBCY:XETRA iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.05 (+0.65%)

USD0.11B
IS07:F iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.01 (+0.13%)

N/A
IBCZ:F iShares Edge MSCI World M.. 0.00 % 0.50 %

+0.01 (+0.18%)

USD0.55B
IBCY:F iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.02 (+0.23%)

USD0.10B
UFSD:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.03 (+0.39%)

USD1.22M
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.50 %

+0.03 (+0.35%)

USD0.54B
IFSU:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.04 (+0.42%)

USD0.11B
FSUS:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+7.75 (+1.11%)

USD0.11B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

-0.12 (-0.04%)

USD1.08B
ACWF iShares MSCI Global Multi.. 0.00 % 0.35 %

-0.23 (-0.61%)

USD0.10B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.85 %

-0.03 (-0.35%)

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 0.85 %

-0.04 (-0.48%)

USD0.33B
XFS:CA iShares MSCI Multifactor .. 0.00 % 0.45 %

N/A

USD0.07B
XFA:CA iShares MSCI Multifactor .. 0.00 % 0.45 %

N/A

USD0.03B
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

-0.28 (-0.68%)

USD0.12B
PBI Pitney Bowes Inc 0.00 % 0.00 %

-0.03 (-0.36%)

USD1.44B
LRGF iShares MSCI USA Multifac.. 0.00 % 0.20 %

-0.36 (-0.85%)

USD0.98B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

-0.20 (-0.43%)

USD0.05B
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.03 (+0.35%)

USD5.61M

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.28% 63% D 75% C
Dividend Return 0.35% 40% F 23% F
Total Return 18.63% 63% D 75% C
Trailing 12 Months  
Capital Gain 45.20% 75% C 51% F
Dividend Return 1.52% 60% D- 19% F
Total Return 46.73% 75% C 49% F
Trailing 5 Years  
Capital Gain 157.44% 63% D 88% B+
Dividend Return 10.70% 80% B- 34% F
Total Return 168.14% 63% D 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 22.54% 50% F 88% B+
Dividend Return 1.47% 67% D+ 35% F
Total Return 24.01% 63% D 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 22.71% 50% F 44% F
Risk Adjusted Return 105.73% 50% F 93% A
Market Capitalization 93.41B 75% C 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.21 38% F 41% F
Price/Book Ratio 2.77 50% F 38% F
Price / Cash Flow Ratio 8.74 38% F 49% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 14.08% 50% F 78% C+
Return on Invested Capital 8.70% 63% D 71% C-
Return on Assets 6.29% 63% D 86% B
Debt to Equity Ratio 58.24% 63% D 58% F
Technical Ratios  
Short Ratio 2.54 50% F 36% F
Short Percent 1.55% 50% F 75% C
Beta 1.05 13% F 51% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.